The A3 Adenosine Receptor as a New Target for Cancer Therapy and Chemoprotection
- 1 October 2001
- journal article
- Published by Elsevier in Experimental Cell Research
- Vol. 269 (2) , 230-236
- https://doi.org/10.1006/excr.2001.5327
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Resistance of Muscle to Tumor Metastases: A Role for A3 Adenosine Receptor AgonistsNeoplasia, 2001
- Adenosine acts as an inhibitor of lymphoma cell growthEuropean Journal Of Cancer, 2000
- Induction of Apoptosis in Rat Cardiocytes by A3 Adenosine Receptor Activation and Its Suppression by IsoproterenolExperimental Cell Research, 2000
- Activation of the A3 adenosine receptor affects cell cycle progression and cell growthNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 2000
- Telomerase expression in uveal melanomaBritish Journal of Ophthalmology, 2000
- Stimulation of Adenosine A3Receptors in Cerebral Ischemia: Neuronal Death, Recovery, or Both?Annals of the New York Academy of Sciences, 1999
- Functionalized Congeners of 1,4-Dihydropyridines as Antagonist Molecular Probes for A3 Adenosine ReceptorsBioconjugate Chemistry, 1999
- Synthesis, CoMFA Analysis, and Receptor Docking of 3,5-Diacyl-2,4-Dialkylpyridine Derivatives as Selective A3 Adenosine Receptor AntagonistsJournal of Medicinal Chemistry, 1999
- The effects of adenosine A3 receptor stimulation on seizures in miceEuropean Journal of Pharmacology, 1995
- Rapid flow cytofluorometric analysis of mammalian cell cycle by propidium iodide staining.The Journal of cell biology, 1975